Patents by Inventor Elaine Coustan-Smith

Elaine Coustan-Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Approach for universal monitoring of minimal residual disease in acute myeloid leukemia
    Patent number: 11709164
    Abstract: Methods for detecting the presence of proteins in a subject are described. The proteins detected can be indicative of acute myeloid leukemia (AML). The proteins can be particularly useful for monitoring minimal residual disease (MRD) in AML.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: July 25, 2023
    Assignees: National University of Singapore, St. Jude Children's Research Hospital, Inc.
    Inventors: Dario Campana, Elaine Coustan-Smith
  • A New Approach For Universal Monitoring Of Minimal Residual Disease In Acute Myeloid Leukemia
    Publication number: 20200340995
    Abstract: Methods for detecting the presence of proteins in a subject are described. The proteins detected can be indicative of acute myeloid leukemia (AML). The proteins can be particularly useful for monitoring minimal residual disease (MRD) in AML.
    Type: Application
    Filed: October 26, 2018
    Publication date: October 29, 2020
    Inventors: Dario Campana, Elaine Coustan-Smith
  • Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
    Patent number: 9777332
    Abstract: This invention provides methods and kits for diagnosing, ascertaining the clinical course of minimal residual disease associated with acute lymphoblastic leukemia (ALL). Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with diseases associated with ALL based on patterns of surface marker expression unique to ALL.
    Type: Grant
    Filed: March 14, 2012
    Date of Patent: October 3, 2017
    Assignee: St. Jude Children's Research Hospital
    Inventors: Dario Campana, Elaine Coustan-Smith
  • METHODS AND COMPOSITIONS FOR IDENTIFYING MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20140148354
    Abstract: This invention provides methods and kits for diagnosing, ascertaining the clinical course of minimal residual disease associated with acute lymphoblastic leukemia (ALL). Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with diseases associated with ALL based on patterns of surface marker expression unique to ALL.
    Type: Application
    Filed: March 14, 2012
    Publication date: May 29, 2014
    Applicant: ST. JUDE CHILDREN'S RESEARCH HOSPITAL
    Inventors: Dario Campana, Elaine Coustan-Smith